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Normal human epidermal keratinocytes have been
shown to express a cell-type-speci¢c pattern of extrahe-
patic cytochrome P450 enzymes and e¥ux transport
proteins showing that these cells metabolize and excrete
a variety of xenobiotics. Recently transport proteins in-
volved in the uptake of xenobiotics have been detected
and here we analyzed the mRNA and protein expres-
sion pro¢les and functional activities of these proteins
in human keratinocytes in comparison to primary liver
cells. The transporters studied included the subtypes A,
B, C, D, and E of the organic anion transporting poly-
peptide (OATP) family, which are responsible for the
uptake of various anionic and neutral molecules and
especially organic cations ^ including drugs. Constitu-
tive expression of OATP-B, OATP-D, and OATP-E
was shown for the ¢rst time in normal human epider-
mal keratinocytes on a molecular level using reverse
transcription polymerase chain reaction and northern
blot analysis, as well as in human skin tissue shown by
tissue blot hybridization and immunohistochemistry.
Expression of OATP-A and OATP-C was not detected
in any of the keratinocyte samples. In contrast, liver
tissue showed a signi¢cant expression of OATP-A and
OATP-B as well as OATP-C, a weak expression of
OATP-D, and no expression of OATP-E. These data re-
vealed that normal human epidermal keratinocytes ex-
press a speci¢c pro¢le of transporters involved in drug
in£ux. Using a newly developed uptake-transport assay,
uptake of known and well-characterized OATP sub-
strates like estradiol-17b-glucuronide and estrone sulfate
was inhibited in normal human epidermal keratino-
cytes by speci¢c inhibitors such as taurocholate, verify-
ing the functional capacity of the expressed OATPs.
Human dermal ¢broblasts seem to have a lower in£ux
transport activity for estradiol-17b-glucuronide, which
correlates with the immunohistologic data. Even
though the substrate speci¢city of the OATP isoforms
is only partially known until now, our ¢ndings support
the concept that uptake of large organic cations like
drugs in keratinocytes is an active transport process
mediated by members of the OATP family. Key words:
skin barrier/drug uptake. J Invest Dermatol 120:285 ^291,
2003
U
ptake of xenobiotics into normal human epider-
mal keratinocytes (NHEKs) and subsequent ex-
cretion of these substances has long been thought
to be a process of passive di¡usion. Recently we
were able to demonstrate that e¥ux of large or-
ganic cations such as drugs is mediated by ATP binding cassette
transporters such as MRP1, MRP3^7, and MDR1 (Baron et al,
2001). This study revealed that NHEKs express various metabolic
active and transport associated enzymes and are therefore capable
of metabolizing and eliminating xenobiotics. Other studies by
Abels et al (2000) showed that the cellular uptake of indocyanine
green in HaCaT keratinocytes is inhibited by bromosulfophtha-
lein indicating the possible involvement of an organic anion
transporting polypeptide (OATP) in the active uptake of organic
cations like indocyanine green.
Organic anion transporting polypeptide 1 (oatp1) was ¢rst
identi¢ed at the molecular level in rats as a multispeci¢c and
sodium-ion-independent transporter for various organic anions,
including bile acids, conjugated metabolites, and xenobiotics (Jac-
quemin et al, 1994). Subsequently, rat oatp2 and oatp3 were iso-
lated as homologs of oatp1 and were shown to be present in
various tissues and to transport anionic and neutral compounds
(Noe et al, 1997). As these transporters are structurally very closely
related, they are considered to form a single protein family ^ the
OATP family. In humans OATP-A (SLC21A3) was ¢rst cloned
from human liver as a homolog of rat oatp1 (Kullak-Ublick
et al, 1995). Tamai et al (2000) identi¢ed three novel transporters
OATP-B (SLC21A9), OATP-D (SLC21A11), and OATP-E
(SLC21A12), structurally belonging to the OATP family. These
OATPs exhibit a broad and to a certain degree overlapping sub-
strate speci¢city and transport a wide range of large organic
compounds including steroid conjugates, cardiac glycosides, en-
dothelin antagonists, and certain toxins (Tamai et al, 2000).
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Skin is the major interface between the environment and the
body and therefore is exposed to various xenobiotics. Little is
known, however, about the expression and function of in£ux
transport proteins in human skin and the role of their interaction
in uptake of such xenobiotics as well as endogenous substrates.
This prompted us to analyze the expression pattern and func-
tional activity of polyspeci¢c membrane transporters, such as
OATP-A, OATP-B, OATP-C, OATP-D, and OATP-E, in
NHEKs.
MATERIALS AND METHODS
Chemicals All reagents were of highest grade and purity commercially
available.
Keratinocytes NHEKs were obtained from foreskin by dispase (Roche,
Mannheim, Germany) separation of the epidermal sheet from the dermis
and subsequent trypsin/ethylenediamine tetraacetic acid (EDTA) (PAA,
Linz, Austria) digestion of the epidermis. The keratinocytes were cultured
in low calcium (0.09 mM), serum-free, keratinocyte medium with bovine
pituitary gland extract, recombinant human epidermal growth factor,
insulin, gentamycin sulfate, and amphotericin B as described by the
manufacturer (KGM, Clonetics, San Diego, CA). Cells were subcultivated
by using the manufacturer’s detach kit with Hank’s balanced salt solution
and trypsin/EDTA.The mediumwas replaced regularly three times a week.
Cells used for this study were in second and third passage in late
subcon£uency. Induction was performed by the addition of inducers,
dissolved in water.
Fibroblasts Normal human ¢broblasts were obtained from foreskin
specimens. After excision, the specimens were washed three times in
sterile phosphate-bu¡ered saline (PBS; PAA) containing antibiotics
(penicillin/streptomycin; PAA) and antimycotics (amphotericin B;
Boehringer Mannheim, Germany), and digested in dispase solution (2 U
per ml, GibcoBRL, Karlsruhe, Germany) for 20 h at 41C and
subsequently for 2 h at 371C. Then, the epidermis was removed and, for
adherence to the polystyrene surface, the dermis was placed in a dry cell
culture multiwell plate (FALCON-Becton Dickinson, Franklin Lakes, NJ)
for 20 min. Following this, Dulbecco’s minimum essential medium with
high glucose and L-glutamine (GibcoBRL), 10% fetal bovine serum
(FBS; Biochrom, Berlin, Germany) was added. The plates were
transferred to a CO2 incubator (MCO-17AI, Sanyo, Japan) at 371C in a
humidi¢ed atmosphere with 5% CO2. Monitoring ¢broblast outgrowth
by light microscopy (LEICA DMIL; Leitz, Wetzlar, Germany), dermis
was removed after 5^7 d. After reaching the state of early con£uence, cells
were washed with PBS and incubated in 1 ml trypsin/EDTA (PAA) for 3
min at 371C. The enzymatic digestion was stopped by addition of 3 ml
FBS. Then, cells were centrifuged, the supernatant was discarded, and the
cells were suspended in FBS or autologous serum and subcultivated in cell
culture £asks (Nunc, Roskilde, Denmark).
RNA isolation mRNAwas extracted using 5106 keratinocytes from
di¡erent donors with the Oligotex direct mRNA puri¢cation kit (Qiagen,
Hilden, Germany) using the mRNA enrichment protocol (Kuribayashi
et al, 1988). The mRNA concentration of each sample was measured using
the Eppendorf BioPhotometer (Eppendorf, Hamburg, Germany) and
equal amounts of mRNA were used for reverse transcription. Puri¢ed
mRNA and total RNA from human liver was used as control (Clontech,
Palo Alto, CA).
Reverse transcription polymerase chain reaction (RT-PCR) RT-
PCR was performed with the GeneAmp RNA PCR kit (Perkin Elmer,
Weiterstadt, Germany) according to the manufacturer’s instructions. All
RT-PCR experiments were performed in duplicate for each donor.
Detection of speci¢c mRNAs for OATP-AOATP-E was achieved using
primers designed to amplify at least one intron in the gene to exclude
contamination of cDNAwith genomic DNA (Table I). b-Actin was used
as an internal standard as described before (Baron et al, 1998). Ampli¢cation
was carried out with 35 cycles of 1 min denaturation at 931C, 1 min
annealing at 541C, and 1 min extension at 721C. Ampli¢cation was
terminated with an extension step of 5 min duration after the last cycle.
PCR products were separated on 1.0% agarose gels (1TBE) and stained
with ethidium bromide.
Northern blot analysis Total RNA was isolated using peqGOLD
RNA-Pures (peqlab, Erlangen, Germany) as described by the
manufacturer. Twenty micrograms of total RNA were separated on 1.5%
denaturating agarose gels and transferred to positively charged nylon
membranes (Roche). The membranes were prehybridized at 451C for 2 h
in ULTRAhyb hybridization bu¡er (Ambion, Austin,TX) and hybridized
overnight in the same solution with a-32P-cDNA fragments labeled with
the DECAprime II DNA labeling kit (Ambion). Blots were washed twice
with 2 sodium citrate/chloride bu¡er (SSC), 0.1% sodium dodecyl sulfate
(SDS) for 1 h at 501C, followed by two washing steps for 30 min with
0.1SSC, 0.1% SDS at 501C. Afterwards blots were exposed to Kodak
X-OMATAR-5 ¢lm at 701C with intensifying screens.
Tissue blot Human conceptional normal tissue northern blots
containing 20 mg of total RNA per lane from four di¡erent human
tissues (Genpak, Hampshire, U.K.) were prehybridized at 451C for 2 h in
ULTRAhyb hybridization bu¡er (Ambion) and hybridized overnight in
the same solution containing a-32P-cDNA fragments labeled with the
DECAprime II DNA labeling kit (Ambion). Blots were washed twice
with 2 SSC, 0.1% SDS for 1 h at 501C, followed by two washes for
30 min with 0.1SSC, 0.1% SDS at 501C, and were then exposed to
Kodak X-OMATAR-5 ¢lm at ^701C with intensifying screens.
Transport assay Cells were grown in 24-well plates to about 90%
con£uency. Twenty-four hours before starting the uptake experiment the
cell culture medium was replaced by serum-free medium. Cells were
washed once with prewarmed PBS and then incubated with 500 ml of
serum-free medium containing di¡erent concentrations of the inhibitor
taurocholate (Sigma, Deisenhofen, Germany). Control cells were
incubated in serum-free medium without the inhibitor. After incubation
for 30 min at 371C another 500 ml medium containing the tritium-labeled
substrates 17b-D-glucuronide [estradiol-6,7^3H(N)] or estrone sulfate
[6,7^3H(N)] (Perkin Elmer, Weiterstadt, Germany) with or without
taurocholate were added. After incubation for 60 min at 371C the
radioactive medium was removed and cells were washed three times with
PBS. Cells were lyzed by adding Optiphase ‘‘Supermix’’ (Wallac, Turku,
Finland). The cell-associated radioactivity was determined by transferring
500 ml aliqouts of the lysate in a £exible 24-well plate and counting
Table I. Primers used for RT-PCR analysis
Sense primer location Antisense primer location PCR product
OATP-A AAGAAGAGGTCAAGAAGGAAAAAT GGAGCATCAAGGAACAGTCAGGTC 661
924^948 1561^1584
OATP-B CGTGCGGCCAAGTGTGTTCCATAA ACAAGGATAGCCCCATAGCCAATC 259
295^318 530^553
OATP-C TGTCATTGTCCTTTTACCTATTAT TGTAAGTTATTCCATTGTTTCCAC 195
1349^1372 1519^1543
OATP-D CTCAAATCCTTCGCCTTCATCCTG AGGGTCAGAGTAGAGGCAAAGAAC 129
2090^2113 2194^2218
OATP-E CACGGCGGGCACTCAGCATTTCCT CGATCGGGTATAAAACACATTCTA 240
2283^2306 2499^2522
b-actin ACCCACACTGTGCCCATCTA CGGAACCGCTCATTGCC 290
488^507 761^777
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radioactivity using a cross-contamination preventing tape and a Wallac
1450 MicroBetasTriLux liquid scintillation counter (Wallac).
Bioluminescent somatic cell cytotoxicity assay The cytotoxicity of
drugs was determined using a bioluminescent somatic cell assay kit
(Sigma) according to the manufacturer’s instructions. This kit was
employed for the bioluminescent determination of the ATP released from
a suspension of viable somatic cells. The number of viable somatic cells is
selectively counted because, as a cell dies, its ATP amount is rapidly
degraded. Brie£y, cells were plated in 24-well microtiter plates at an
appropriate density and allowed to adhere overnight before the addition
of di¡erent taurocholate concentrations. Incubation with taurocholate was
carried out for 2 h; the amount of cell death was then assessed by the
addition of 500 ml of ATP-releasing agent. 7.5 ml of this cell sample were
added to a vial containing 0.1 ml of ATP assay mix solution and
immediately the amount of light emitted, L(SAM), was measured with a
luminometer (TD-20/20 Luminometer, Turner Designs, Sunnyvale, CA).
The amount of ATP in the cell sample was then calculated by using an
ATP standard (Lundin et al, 1986).
Immunoblot For isolation of total cellular protein, cells were harvested
by trypsin treatment and resuspended in a bu¡er containing 10 mM sodium
phosphate (pH 8.0), 1mM EDTA, and 2 mM dithiothreitol. Cells were lyzed
using an MSE Soniprep 150 sonicator. Protein concentration was
determined spectrophotometrically using the Bradford reagent (Bio-Rad,
Munich, Germany) and bovine serum albumin as standard.
For detection of OATP-A and OATP-B, samples were denaturated
by suspension in Laemmli sample bu¡er (Bio-Rad) containing 5%
b-mercaptoethanol. Generally 100 mg of protein was loaded per lane. The
expression of the transport proteins was analyzed by using antiserum
against a C-terminal fusion protein of human OATP-A (Gao et al, 2000)
and antiserum against a C-terminal peptide of human OATP-B (Kullak-
Ublick et al, 2001), kindly provided by Dr. Bruno Stieger, Department of
Medicine, Division of Clinical Pharmacology and Toxicology, University
Hospital Zˇrich, Switzerland. Using 7.5% TrisHCl Criterion Precast
Gels (Bio-Rad) blotting was performed onto 0.45 mm cellulose nitrate
sheets (Schleicher & Schuell, Dassel, Germany) according to the method
of Towbin et al (1979) for 1 h with 200 V. Following blocking the
remaining protein binding sites on the membrane with nonfat dry milk
powder in PBS containing 0.1% Tween 20 (Sigma, Taufkirchen,
Germany) (MPBST) we incubated the blot in the primary antibody
solution (each 1:1000^1: 2000 in MPBST) overnight. After subsequent
washing steps the blot was incubated in the secondary antibody solution
(each 1:1000 in MPBST) for 4 h. Secondary antibodies were coupled to
horseradish peroxidase and were detected after subsequent washing steps
using the enhanced chemiluminescence Western blotting kit (Amersham,
Little Chalfont, U.K.) according to the manufacturer’s instructions.
Immunhistochemistry Para⁄n-embedded skin specimens were cut
into 4 mm sections, mounted on superfrost slides (Menzel, Braunschweig,
Germany), depara⁄nized, and rehydrated. To unmask antigens the sections
were pretreated withTarget Retrieval pH 6.1 (DAKO, Glostrup, Denmark),
as indicated in the work sheet, and rinsed in distilled water and Tris-
bu¡ered saline (TBS). Following this, slides were incubated for 30 min
with primary antibody, either the polyclonal antibody speci¢c for OATP-
B or the isotypic control, and rinsed inTBS for 10 min. For visualization of
the staining the DAKO EnVisionTM system was used according to the
manufacturer’s instructions. Finally sections were counterstained with
hematoxylin and mounted with a coverslip. Examination and photo
documentation was performed using an inverse photomicroscope (LEICA
DMIL).
Immuno£uorescence For immuno£uorescent examination frozen
human foreskin specimens were cut into 4 mm sections. The sections were
¢xed in acetone, dried, and rehydrated in TBS for 10 min. Afterwards
sections were stained with primary antibodies, either the polyclonal
antibody speci¢c for OATP-B or the isotypic control, and rinsed in TBS
for 10 min. Then sections were incubated for 45 min with a secondary
£uorochrome conjugated antirabbit antibody, washed with TBS, and
mounted with Fluorprep (bioMerieux, Marcy l’Etoile, France). Sections
were examined with ultraviolet light and subsequently photo documented
using a photomicroscope (DMIL) equipped with epi£uorescence
illumination.
RESULTS
mRNA expression of the OATP Expression of the subtypes
A, B, C, D, and E of the OATP family was assessed by RT-PCR
in proliferating keratinocytes derived from the human epidermis
of di¡erent donors and adult liver tissue. Similar amounts of
template mRNA were used for each RT-PCR using di¡erent
OATP primer pairs (Table I). The results of these RT-PCR
studies are displayed in Fig 1. Keratinocytes revealed constitutive
expression of OATP-B, OATP-D, and OATP-E, whereas
expression of OATP-A and OATP-C was not detected in any
of the keratinocyte samples. In contrast, liver tissue showed
signi¢cant expression of OATP-A and OATP-B as well as
OATP-C and a weak expression of OATP-D (Figs. 1, 2a, b).
Expression of OATP-E in hepatocytes was not detected by RT-
PCR (Fig 1). Addition of tumor necrosis factor a (TNF-a) and
dexamethasone to keratinocytes revealed no change in expression
level of OATP-AOATP-E (Fig 1).
Northern blot analysis revealed a strong expression of OATP-
D in keratinocytes of several independent donors (Fig 2a,b). In
contrast to RT-PCR analysis the expression of this transport
protein could not be detected in liver or in HepG2 cells using
northern blot analysis (Fig 2a,b). Expression of OATP-E
mRNA in human keratinocytes could be proved by northern
blot analysis (Fig 2c).
Using tissue blot hybridization, OATP-D mRNA expression
could be detected in human skin but not in human heart,
kidney, and small intestine tissues (Fig 3).
Expression of OATP proteins RT-PCR results were
con¢rmed by immunoblots using speci¢c antibodies directed
against OATPs that showed reactivity with OATP-A and
Figure1. RT-PCR analysis of proliferating keratinocytes derived
from the human epidermis using primers speci¢c for various
OATPs and b-actin. RT-PCR analysis of OATP-A, OATP-B, OATP-C,
OATP-D, OATP-E and b-actin expression. Lane 1, donor 1; lane 2, donor 1,
induction with dexamethasone (DEX); lane 3, donor 1, induction with
TNF-a; lane 4, human adult liver; lane 5, DNA marker pBR322 Hae III
Digest. Induction of cells was performed with dexamethasone (10^7 M) or
TNF-a (100 U per ml) for 24 h.
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OATP-B (Fig 4). A strong expression of OATP-A and OATP-B
was detected in human liver tissue, whereas only a weak band
could be demonstrated for OATP-B in NHEKs of donors 1 and
2 (Fig 4). In accordance with RT-PCR data no expression of
OATP-A was revealed in protein lysate of NHEKs (Fig 4).
Speci¢c antibodies against OATP-D and OATP-E were not
available for study.
Immunohistochemistry and immuno£uorescence The
immunhistochemical and immuno£uorescent staining revealed
that OATP-B is expressed in all layers of the epidermis (Fig
5a,c). No positive staining could be detected in the isotype
controls (Fig 5b,d).
Functional activity of OATPs in NHEKs A novel uptake-
transport assay for the detection of OATP-mediated in£ux
transport in NHEKs and ¢broblasts was established, using 3H-
estradiol-17b-glucuronide as a substrate and taurocholate as
an inhibitor (Fig 6a). Experiments were performed in
quadruplicate using four di¡erent donors. Pretreatment of
keratinocytes of donor 1 with taurocholate (1 mM) (Fig 6a)
reduced the active uptake of 3H-estradiol-17b-glucuronide in
NHEKs by 23%74.4% (SD) compared to control uptake
measured in the absence of the inhibitor. The degree of
inhibition was augmented using higher concentrations of the
inhibitor such that 5 mmol per l concentration of taurocholate
reduced the relative uptake by an average of 49%73.5% (SD).
Similar results were obtained using keratinocytes from three
other donors showing an overall uptake reduction rate of
23%74.5% (SD) for 1 mmol per l concentration and
44%73.9% (SD) for 5 mmol per l concentration (data not
shown). Incubation of human dermal ¢broblasts (Fig 6c) with
taurocholate at a 5 mmol per l concentration reduced the uptake
of estradiol-17b-glucuronide by 34%711.3% (SD) and by
31%711.5% (SD) for 1 mmol per l concentration. Using the
established uptake-transport assay estrone sulfate was chosen as a
substrate and taurocholate as an inhibitor (Fig 6b). Experiments
were performed in hexaduplicate using two di¡erent donors.
Pretreatment of cells of donor 1 with taurocholate (5 mM) (Fig
6b) reduced the active uptake of estrone sulfate in NHEKs by
33%711.6% (SD) compared to control uptake measured in the
absence of the inhibitor. Taurocholate in a 1 mM concentration
reduced estrone sulfate uptake by 31%74.5% (SD).
E¡ect of taurocholate on cell activity Bioluminescent
somatic cell cytotoxicity assay using di¡erent concentrations of
taurocholate as substrate (Fig 6d) revealed a 1.5% reduction in
viable cells determined by ATP content for the 1 mmol per l
concentration and a 3% reduction for 5 mmol per l
concentration.
DISCUSSION
Skin is a major interface between the body and the environment.
Several studies have demonstrated that the skin is not only just a
physical barrier to the environment but that it has the capability
of reacting biochemically with most xenobiotica by xenobiotica
metabolizing enzymes (Jugert et al, 1994; Baron et al, 2001). In
recent years an important role for in£ux transport proteins of
the OATP family has been shown in hepatocytes (Kullak-Ublick
et al, 2001). OATPs represent multispeci¢c transporters that med-
iate, in addition to conjugated and unconjugated bile salts, the
uptake of a vast variety of other amphipathic organic compounds,
including bromosulfophthaleine, steroids and steroid conjugates
like estradiol 17b-glucuronide and estrone-3-sulfate, thyroid
hormones, peptides, leukotriene C4/E4, prostaglandine E2,
Figure 2. Northern blot analysis of OATP mRNA expression in
keratinocytes derived from human epidermis of di¡erent donors,
in HepG2 cells and in human adult liver. Twenty micrograms total
RNA were subjected to northern blot analysis for OATP-D (a, b) and
OATP-E (c). Equal amounts of RNA are indicated by the 18 S rRNA.
Figure 3. Analysis of OATP-D expression in di¡erent human tissues
studied by northern blot analysis. A human multiple tissue northern
blot containing 20 mg of total RNA per lane was hybridized using an
a-32P-cDNA fragment of OAPT-D as probe. b-actin was used as loading
control.
Figure 4. Immunoblots with antibodies against OATP. The expres-
sion of OATP-A and OATP-B was detected via 7.5% SDS polyacrylamide
gel electrophoresis using speci¢c antibodies. Generally, 100 mg of protein are
loaded per lane. The protein bands were detected on an autoradiography
¢lm using enhanced chemiluminescence. Lanes 1, 2, donors 1 and 2; lane 3,
human adult liver tissue.
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Figure 5. Immunohistochemistry and immuno£uorescence. Immu-
nohistochemistry: formalin-¢xed and para⁄n-embedded skin specimen
stained with a polyclonal antibody speci¢c for OATP-B (a), and isotype
control (b). Immuno£uorescence: frozen skin specimen stained with a poly-
clonal antibody speci¢c for OATP-B (c), and isotype control (d). }, Posi-
tive stained keratinocytes located in all layers of the epidermis. (b), (d)
Isotypic controls; no positive staining detectable.
Figure 6. The inhibitory e¡ect of taurocholate on the uptake of
17b-D-glucuronide [estradiol-6,7^3H(N)] and estrone sulfate
[6,7^3H(N)] by OATP and its cytotoxicity in primary human kera-
tinocytes and dermal ¢broblasts. (a) Uptake of 17b-D-glucuronide [es-
tradiol-6,7^3H(N)] was measured in quadruplicate in NHEKs (donor 1)
for 60 min in the presence of taurocholate (1 and 5 mmol per l) and in the
absence of the inhibitor. (b) Uptake of estrone sulfate [6,7^3H(N)] was
measured in quadruplicate in NHEKs (donor 1) for 60 min in the presence
of taurocholate (1 and 5 mmol per l) and in the absence of the inhibitor. (c)
Uptake of 17b-D-glucuronide [estradiol-6,7^3H(N)] was measured in
quadruplicate in dermal ¢broblasts (donor 1) for 60 min in the presence
of taurocholate (1 and 5 mmol per l) and in the absence of the inhibitor.
(d) For the cytotoxicity assays NHEKs were incubated with taurocholate
(1 and 5 mmol per l) for 2 h. The amount of cell death was then assessed
by the release of ATP calculated by use of an ATP standard. Results of the
cytotoxicity assay are displayed as median values.
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mycotoxines, and numerous drugs like pravastatine and benzyl-
penicillin (Kullak-Ublick et al, 2000; Meier and Stieger, 2002).
Although several of these endogenous and exogenous com-
pounds are relevant to dermatology, nothing was known about
the expression pro¢le and functional activities of these in£ux
transport proteins in human skin tissue and especially in normal
human keratinocytes.
The molecular and functional characterization of transport
proteins is emerging rapidly, however, and a signi¢cant number
of drugs have been shown to be substrates or inhibitors (Kim,
2000). In the liver, transport proteins are present on the sinusoidal
membrane, and may be crucial for the hepatic clearance of several
drugs (Kamisako et al, 1999). In particular the OATP family of
sinusoidal transporters is known to be important in this process.
These OATP transporters were detected at signi¢cant levels in
various other tissues and cell lines although the expression pat-
tern in skin tissue has not been analyzed so far (Tamai et al,
2000). OATP proteins are expressed ubiquitously in fetal tissue,
whereas expression in adult tissue is variable. In our study we re-
vealed a constitutive expression of OATP-B, OATP-D, and
OATP-E in NHEKs using RT-PCR (Fig 1) and northern blot
analysis (Fig 2a^c), as well as in skin tissue shown by tissue blot
hybridization (Fig 3). Expression of OATP-B was detected in the
epidermis of skin specimens by immuno£uorescence and immu-
nohistochemistry (Fig 5a,c); expression of OATP-D and OATP-
E could not be analyzed in human skin as speci¢c antibodies
against these proteins are not available. Expression of OATP-A
and OATP-C was not detected in any of the samples (Figs 1, 4).
In contrast, liver tissue revealed a di¡erent expression pro¢le
of OATPs showing a signi¢cant expression of OATP-A and
OATP-B as well as OATP-C and a weak expression of OATP-D
(Figs 1, 2, 4). Expression of OATP-E was not detected by RT-
PCR (Fig 1). These expression pro¢les could point to their phy-
siologic roles in vivo. Expression of OATP-C for example is
strongly and exclusively expressed in liver, suggesting a crucial
role in this tissue. OATP-E is expressed in di¡erent tumor tissues
and skin cells but not in liver (Fig 1) and normal blood cells
(Tamai et al, 2000). Such an expression pro¢le might be useful
for transporter-mediated delivery of anticancer agents to tumors
of the skin without accumulation in blood cells, which often
causes severe side-e¡ects. In contrast to many e¥ux transporters,
OATP proteins reveal major di¡erences in their substrate speci¢-
city (van Montfoort et al, 1999) and comparison of 16 transport
substrates revealed that OATP-B has the smallest substrate spec-
trum (Meier et al, 1997). Therefore the expression pattern of
OATPs in NHEKs has an important in£uence on the spectrum
of substances that enter the cell by active transport. In addition
the polymorphic expression of, for example, OATP-B has been
shown to a¡ect the physiologic and/or pharmacologic e¡ects of
OATP-B substrates (Nozawa et al, 2002).
Studies by Sugiyama et al (2001) and Tamai et al (2000) have
shown that estradiol-17b-glucuronide is a well-characterized sub-
strate for OATP transporters such as OATP-C and OATP-E.
High activity of estrone-3-sulfate transport was reported for
OATP-B and OATP-C, intermediate activity for OATP-E, and
low activity for OATP-D (Tamai et al, 2000). Estrogens are hor-
mones with wide-ranging biologic e¡ects and skin is an impor-
tant target organ for estrogens. The major e¡ects of estrogens are
as regulators of connective tissue molecules, namely collagen and
hyaluronic acid. Gendimenico et al (2002) showed that application
of topical estrogens increased epidermal thickness and biotrans-
formation of estradiol has been detected in the human keratino-
cyte cell line HaCaT byAltenburger and Kissel (1998). In addition
serum estradiol and estrone measurements in venous blood sam-
ples showed the percutaneous systemic uptake of these substances
following transdermal estradiol gel or patch treatment (Jarvinen
et al, 2000).
OATP-dependent in£ux can be inhibited by nonselective
inhibitors such as probenecid and selective inhibitors such
as taurocholate. Taurocholate has been shown to inhibit
OATP-E-mediated uptake transport (Fujiwara et al, 2001) but is
no substrate for OATP-B (Kullak-Ublick et al, 2001). In our
studies taurocholate revealed no major toxic e¡ect on cultured
NHEKs (Fig 6d).
Using these data we have established a novel in£ux transport
assay in NHEK using estradiol-17b-glucuronide as substrate and
taurocholate as inhibitor (Fig 6a). This assay revealed a reduction
of the active uptake of estradiol-17b-glucuronide in NHEK by
nearly 50% in comparison to control uptake measured in the ab-
sence of the inhibitor (Fig 6a), verifying the active role of the
expressed OATPs. Absolute transport values for keratinocytes
were compared with human dermal ¢broblasts in an additional
transport experiment (Fig 6c). Fibroblasts seem to have a lower
in£ux transport activity, which correlates with the immunohisto-
logic data (Fig 5a,c).
Uptake of estrone sulfate was decreased by 33% (Fig 6b). The
incomplete inhibition of estradiol-17b-glucuronide uptake by
taurocholate can be explained by an incomplete competitive in-
hibition of OATP-D and the missing inhibition of OATP-B.This
would also explain the decreased inhibitory e¡ect of taurocholate
on the uptake of estradiol sulfate, which is a known substrate of
OATP-B. These ¢ndings indicate that OATP-mediated uptake of
xenobiotics and endogenous compounds like estrogens can be in-
hibited by compounds such as taurocholate, but probably also by
topically or systemically administered drugs that are substrates of
OATPs like steroid conjugates or antibiotics (Tamai et al, 2001).
It is still possible that other transport mechanisms for the active
transport of this substrate may be present in keratinocytes,
although signi¢cant levels of other known in£ux transporters
like the organic cation transporter 1 (OCT1) and the organic an-
ion transporters (OAT1-3) could not be detected in NHEKs by
RT-PCR or immunoblot (data not shown).
The presented in£ux assay o¡ers a novel powerful tool for the
detection of speci¢c substrates and inhibitors of the active OATP-
mediated transport in human skin cells. In particular, the role of
OATPs in the active uptake of systemically and topically applied
drugs can be further elucidated using this technique. Develop-
ment of speci¢c inhibitors for the OATP proteins expressed in
human skin would provide a unique tool for future experiments
as well as for therapeutic use.
Recent studies have shown that TNF-a downregulates mRNA
expression of oatp1 and oatp2 in rat liver (Geier et al, 2000). In
addition, rat oatp2 has been shown to be increased by drug-me-
tabolizing enzyme inducers such as dexamethasone mainly at the
protein level (Guo et al, 2002). The molecular mechanism of this
post-translational regulation remains so far unknown, however.
In this study RT-PCR analysis (Fig 1) of NHEKs revealed no
alteration in OATP expression after induction with either TNF-
a or dexamethasone. These ¢ndings suggest target tissue di¡er-
ences in OATP expression in liver and skin cells.
Our prior studies demonstrated that NHEKs possess cyto-
chrome-P450-dependent catalytic activity as well as functional
active e¥ux pumps. In this study we have shown that uptake of
large organic cations such as drugs in keratinocytes is also an ac-
tive transport process mediated by members of the OATP family,
which can be modulated by speci¢c competitive inhibitors,
in vitro. The ultimate fate of endogenous and exogenous substrates
is likely to be the result of multiple processes such as those
described here.
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